PT  - JOURNAL ARTICLE
AU  - Joshua L. Santarpia
AU  - Danielle N. Rivera
AU  - Vicki Herrera
AU  - M. Jane Morwitzer
AU  - Hannah Creager
AU  - George W. Santarpia
AU  - Kevin K. Crown
AU  - David M. Brett-Major
AU  - Elizabeth Schnaubelt
AU  - M. Jana Broadhurst
AU  - James V. Lawler
AU  - St. Patrick Reid
AU  - John J. Lowe
TI  - Transmission Potential of SARS-CoV-2 in Viral Shedding Observed at the University of Nebraska Medical Center
AID  - 10.1101/2020.03.23.20039446
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.23.20039446
4099  - http://medrxiv.org/content/early/2020/03/26/2020.03.23.20039446.1.short
4100  - http://medrxiv.org/content/early/2020/03/26/2020.03.23.20039446.1.full
AB  - Lack of evidence on SARS-CoV-2 transmission dynamics has led to shifting isolation guidelines between airborne and droplet isolation precautions. During the initial isolation of 13 individuals confirmed positive with COVID-19 infection, air and surface samples were collected in eleven isolation rooms to examine viral shedding from isolated individuals. While all individuals were confirmed positive for SARS-CoV-2, symptoms and viral shedding to the environment varied considerably. Many commonly used items, toilet facilities, and air samples had evidence of viral contamination, indicating that SARS-CoV-2 is shed to the environment as expired particles, during toileting, and through contact with fomites. Disease spread through both direct (droplet and person-to-person) as well as indirect contact (contaminated objects and airborne transmission) are indicated, supporting the use of airborne isolation precautions.One Sentence Summary SARS-CoV-2 is shed during respiration, toileting, and fomite contact, indicating that infection may occur in both direct and indirect contact.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork was supported by University of Nebraska internal fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is included in manuscript materials